912 related articles for article (PubMed ID: 16418211)
1. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
2. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
Franks S
J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
[TBL] [Abstract][Full Text] [Related]
3. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
7. PCOS: a diagnostic challenge.
Azziz R
Reprod Biomed Online; 2004 Jun; 8(6):644-8. PubMed ID: 15169578
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
Kauffman RP; Baker TE; Baker VM; DiMarino P; Castracane VD
Am J Obstet Gynecol; 2008 Jun; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
Carmina E
Minerva Ginecol; 2004 Feb; 56(1):1-6. PubMed ID: 14973405
[TBL] [Abstract][Full Text] [Related]
10. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
Anaforoglu I; Algun E; Incecayir O; Ersoy K
Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
[TBL] [Abstract][Full Text] [Related]
11. How polycystic ovary syndrome came into its own.
Azziz R
F S Sci; 2021 Feb; 2(1):2-10. PubMed ID: 35559761
[TBL] [Abstract][Full Text] [Related]
12. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
[TBL] [Abstract][Full Text] [Related]
13. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
14. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
Merino P; Schulin-Zeuthen C; Codner E
Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of polycystic ovary syndrome.
Trivax B; Azziz R
Clin Obstet Gynecol; 2007 Mar; 50(1):168-77. PubMed ID: 17304034
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.
Goodarzi MO; Azziz R
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):193-205. PubMed ID: 16772151
[TBL] [Abstract][Full Text] [Related]
19. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
